Oxidative stress in schizophrenia: pathogenetic and therapeutic implications.
about
Metabolomics of oxidative stress in recent studies of endogenous and exogenously administered intermediate metabolitesA comparison of the nutrient intake of a community-dwelling first-episode psychosis cohort, aged 19-64 years, with data from the UK populationGeneration of superoxide anion radicals and platelet glutathione peroxidase activity in patients with schizophrenia.Altered glycogen metabolism in cultured astrocytes from mice with chronic glutathione deficit; relevance for neuroenergetics in schizophrenia.Perineuronal nets and schizophrenia: the importance of neuronal coatings.DNA-hydrolysing activity of IgG antibodies from the sera of patients with schizophreniaNADPH oxidase elevations in pyramidal neurons drive psychosocial stress-induced neuropathology.Glucocorticoid regulates parkin expression in mouse frontal cortex: implications in schizophrenia.Oxidative stress and psychological disorders.Cognitive function, plasma MnSOD activity, and MnSOD Ala-9Val polymorphism in patients with schizophrenia and normal controls.The potential biomarkers of drug addiction: Proteomic and metabolomic challenges.Oxidative Stress and the Central Nervous System.Relationship between neutrophil/lymphocyte ratio with oxidative stress and psychopathology in patients with schizophrenia.Catalase activity of IgG antibodies from the sera of healthy donors and patients with schizophrenia.Differential effects of antipsychotics on the development of rat oligodendrocyte precursor cells exposed to cuprizone.Mn-superoxide dismutase activity is associated with orofacial involuntary movements in schizophrenia patients with tardive dyskinesia.Effect of ketamine on oxidative stress following lipopolysaccharide administration
P2860
Q26824720-49F9CFB3-0121-4DF9-BAD2-86718AC2B7D6Q31010040-9AB852D7-7964-442C-89E2-4D5FCA9E50A4Q33589462-55D3E0EF-E702-4E1D-82B3-AB69C60C83F5Q33988027-AAB80BE5-D771-4F22-BA3A-9ED54E8BB7ACQ35660845-AD2EF4DD-45AD-4C13-8F76-769C667C9898Q35779904-6EDF05FE-F26A-4A3A-84D4-697D87D8E90DQ36001558-3939FCAD-A955-4D9C-BE57-C2FF202820D0Q37661354-C01F34E2-4BE1-4C71-A7CD-42DCA3E03F99Q37661360-358EE233-0F18-4AA0-A37D-698349F92BD4Q37699340-E3440791-5AE2-4005-A4A8-80697BD07DF5Q38850141-36F203CC-F68D-4AE8-B9FD-5EFB77406666Q38984077-01AC421B-FB2E-4E77-A204-D83D0934C9B0Q39441570-6F19D315-1FCE-4DFF-AE7B-294F567FE473Q42363520-6368BCDA-F950-42D0-88DC-F40878C55CCDQ44281130-4C76D76C-52AD-4172-A41F-374EE7F4584BQ50602362-109D302A-8288-452B-82DF-55CAD186F0DBQ57729902-2D5A1A19-3E54-47ED-8069-C0BC27A1D99D
P2860
Oxidative stress in schizophrenia: pathogenetic and therapeutic implications.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Oxidative stress in schizophrenia: pathogenetic and therapeutic implications.
@en
Oxidative stress in schizophrenia: pathogenetic and therapeutic implications.
@nl
type
label
Oxidative stress in schizophrenia: pathogenetic and therapeutic implications.
@en
Oxidative stress in schizophrenia: pathogenetic and therapeutic implications.
@nl
prefLabel
Oxidative stress in schizophrenia: pathogenetic and therapeutic implications.
@en
Oxidative stress in schizophrenia: pathogenetic and therapeutic implications.
@nl
P2860
P356
P1476
Oxidative stress in schizophrenia: pathogenetic and therapeutic implications.
@en
P2093
Jeffrey K Yao
Ravinder Reddy
P2860
P304
P356
10.1089/ARS.2010.3646
P577
2011-05-04T00:00:00Z